Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
51.37
-1.31 (-2.49%)
Dec 5, 2025, 4:00 PM EST - Market closed
Soleno Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 128.55 | 105.86 | 13.48 | 9.84 | 10.81 | 8.76 | |
| Research & Development | 52.56 | 78.57 | 25.19 | 15.27 | 21.45 | 23.19 | |
| Operating Expenses | 181.11 | 184.43 | 38.67 | 25.11 | 32.26 | 31.95 | |
| Operating Income | -84.27 | -184.43 | -38.67 | -25.11 | -32.26 | -31.95 | |
| Interest Expense | -4.36 | -0.23 | - | - | - | - | |
| Interest & Investment Income | 15.19 | 12.05 | 2.58 | 0.3 | 0.11 | 0.01 | |
| Other Non Operating Income (Expenses) | - | - | -0.18 | 0.03 | 0.51 | 11.64 | |
| EBT Excluding Unusual Items | -73.44 | -172.61 | -36.27 | -24.78 | -31.64 | -20.3 | |
| Other Unusual Items | -5.01 | -3.24 | -2.71 | 0.71 | 0.73 | -4.34 | |
| Pretax Income | -78.45 | -175.85 | -38.99 | -24.07 | -30.91 | -24.64 | |
| Earnings From Continuing Operations | -78.45 | -175.85 | -38.99 | -24.07 | -30.91 | -24.64 | |
| Net Income | -78.45 | -175.85 | -38.99 | -24.07 | -30.91 | -24.64 | |
| Net Income to Common | -78.45 | -175.85 | -38.99 | -24.07 | -30.91 | -24.64 | |
| Shares Outstanding (Basic) | 49 | 40 | 16 | 8 | 5 | 4 | |
| Shares Outstanding (Diluted) | 49 | 40 | 16 | 8 | 5 | 4 | |
| Shares Change (YoY) | 28.16% | 143.61% | 96.40% | 57.90% | 27.39% | 83.41% | |
| EPS (Basic) | -1.62 | -4.38 | -2.36 | -2.87 | -5.81 | -5.90 | |
| EPS (Diluted) | -1.62 | -4.38 | -2.36 | -2.87 | -5.81 | -5.90 | |
| Free Cash Flow | -25.92 | -69.31 | -24.94 | -20.79 | -27.79 | -25.23 | |
| Free Cash Flow Per Share | -0.53 | -1.73 | -1.51 | -2.48 | -5.23 | -6.04 | |
| EBITDA | -82.26 | -182.44 | -36.71 | -23.15 | -30.3 | -30 | |
| D&A For EBITDA | 2.01 | 1.99 | 1.96 | 1.96 | 1.96 | 1.95 | |
| EBIT | -84.27 | -184.43 | -38.67 | -25.11 | -32.26 | -31.95 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.